October 14, 2020
Video
Vivek Subbiah, MD, discusses how the data from selpercatinib have generated excitement for precision medicine in the treatment landscape for patients with RET-driven lung cancer.
September 29, 2020
Video
Vivek Subbiah, MD, shares his take home message regarding the treatment of patients with non–small cell lung cancer who harbor a RET fusion.
August 27, 2020
Video
Vivek Subbiah, MD, discusses the implications of the phase 1/2 LIBRETTO-001 study, which evaluated selpercatinib as treatment of patients with RET fusion-positive non–small cell lung cancer.
August 05, 2020
Video
Vivek Subbiah, MD, discusses the frontline therapeutic options for patients with renal cell carcinoma.